TrialInternational journal of clinical oncology2017

Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003).

Hiroaki Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.